Advancing a Pipeline of Off-The-Shelf Cell Therapies by The Bioverge Podcast published on 2021-06-01T15:33:01Z Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer. Genre Business
